A more recent version of this regulatory record is available. This version is kept only as a historical record. Please see the Record history section for link to the most recent version.
List details
Basic info
Status | Submitted |
---|---|
Submitter | Estonia |
Submitter email | kookemikaal@terviseamet.ee |
Regulatory programme |
|
CLP Annex VI Index Number |
|
Classification
Harmonised classification at the time of the proposal |
|
---|---|
Proposed harmonised classification by the dossier submitter |
|
Intention timeline
Date of intention | 2018-11-16 |
---|---|
Expected date of submission | 2019-12-20 |
Submitted for accordance check | 2019-12-20 |
Documents
Related substances
By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.
Related regulatory records
Record history
The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.
June 15, 2020
- Proposed specific concentration limits by the dossier submitter: ATE 322 mg/kg bw
Aug. 5, 2020
- CLH report: https://echa.europa.eu/documents/10162/88d7329b-fb71-04b6-c27e-12be895c0745
- Deadline for commenting: 2020-10-02
- Final submission date: 2020-07-02
- Hazard classes open for commenting: Carcinogenicity Germ cell mutagenicity Reproductive toxicity Acute Toxicity - inhalation Acute Toxicity - dermal Acute Toxicity - oral Specific target organ toxicity – single exposure Specific target organ toxicity – repeated exposure Skin corrosion/irritation Serious eye damage/eye irritation Respiratory sensitisation Skin Sensitisation Hazardous to the aquatic environment
- Legal deadline for opinion adoption: 2022-01-01
- Status: Submitted → Consultation
- Start of consultation: 2020-08-03
- Submitter email: kookemikaal@terviseamet.ee → kemikaal@terviseamet.ee
Oct. 14, 2020
- Status: Consultation → Opinion Development
Oct. 27, 2020
- Comments received: https://echa.europa.eu/documents/10162/28ba5043-bbdf-3626-5a99-7ccad69979ba
- Public consultations - received attachments: https://echa.europa.eu/documents/10162/3816c24b-3fa8-e454-5aac-ee42013446fc
- Public consultations - received attachments: https://echa.europa.eu/documents/10162/480adf7d-d637-a255-3570-a74fd75d5ba6
- Public consultations - received attachments: https://echa.europa.eu/documents/10162/4f0e2748-83d0-a8fb-7027-ef24796c91fa
- Public consultations - received attachments: https://echa.europa.eu/documents/10162/6f9a0c92-4737-416f-1b0e-883da9514acc
- Public consultations - received attachments: https://echa.europa.eu/documents/10162/979b1e10-5f23-f22d-a497-06119446d074
- Public consultations - received attachments: https://echa.europa.eu/documents/10162/a8cc8d5c-ef37-28b6-8df9-e90f3b2a55d2
- Public consultations - received attachments: https://echa.europa.eu/documents/10162/c10516ac-b043-6e62-1dab-781a3e661671
Feb. 15, 2021
- Public consultations - received attachments: https://echa.europa.eu/documents/10162/32aae9bc-bdfa-7303-ab61-ebbc6de21a33
- Public consultations - received attachments: https://echa.europa.eu/documents/10162/480adf7d-d637-a255-3570-a74fd75d5ba6
March 27, 2021
- CLH report: https://echa.europa.eu/documents/10162/88d7329b-fb71-04b6-c27e-12be895c0745 → https://echa.europa.eu/documents/10162/6f91b220-5be4-1f2a-68ff-d01565c6495b
- Annexes to the CLH Report: https://echa.europa.eu/documents/10162/492f8e01-81b7-ad1d-c910-497b5a5197eb
- Harmonised classification at the time of the proposal: Aquatic Chronic 1, M-factor=10
- Proposed harmonised classification by the dossier submitter: Aquatic Chronic 1, M-factor=10 → Aquatic Chronic 1, M-factor=100
March 31, 2021
- Name: metribuzin (ISO); 4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one → 4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-one;4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one;metribuzin (ISO)
April 8, 2021
- Name: 4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-one;4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one;metribuzin (ISO) → metribuzin (ISO); 4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one
- Comments received: https://echa.europa.eu/documents/10162/3c42c1af-34e7-b59d-92f5-40b9a78da46c
July 1, 2021
- Date of opinion: 2021-06-10
- Status: Opinion Development → Opinion Adopted
Oct. 8, 2021
- Background document: https://echa.europa.eu/documents/10162/43cebf3b-656e-84c5-d5ed-4e33e374c201
- Comments received: https://echa.europa.eu/documents/10162/28ba5043-bbdf-3626-5a99-7ccad69979ba → https://echa.europa.eu/documents/10162/53246f3f-f1bc-5bf8-0f79-fa5bd056b384
- Comments received: https://echa.europa.eu/documents/10162/3c42c1af-34e7-b59d-92f5-40b9a78da46c → https://echa.europa.eu/documents/10162/8c0cd728-7d61-e65a-f21b-57861350e141
- Proposed specific concentration limits by the dossier submitter: ATE 322 mg/kg bw → oral: ATE 322 mg/kg bw
- RAC opinion: https://echa.europa.eu/documents/10162/fd3d9ab4-78c9-1b63-650f-e3615325bbcc
This version
March 16, 2020
- Submitter email: kookemikaal@terviseamet.ee
Feb. 25, 2020
- Proposed harmonised classification by the dossier submitter: Acute Tox. 4, H302
Feb. 24, 2020
- Proposed harmonised classification by the dossier submitter: Acute Tox. 4*, H302
Jan. 14, 2020
- Proposed harmonised classification by the dossier submitter: Specific target organ toxicity - repeated exposure → STOT RE 2, H373
- Status: Intention → Submitted
- Submitted for accordance check: 2019-12-20
June 18, 2019
- Proposed harmonised classification by the dossier submitter: Specific target organ toxicity – repeated exposure → Specific target organ toxicity - repeated exposure
April 9, 2019
- Expected date of submission: 2019-03-31 → 2019-12-20
April 4, 2019
- Regulatory programme: PPP → Active substance in Plant Protection Products
Feb. 18, 2019
- Regulatory programme: Active substance in Plant Protection Products under the Annex I Renewal (AIR) process (Regulation (EC) No. 1141/2010 or Regulation (EC) No. 844/2012) → PPP
Add the related substance to your watchlist to monitor this regulatory record.